Canine oral mucosal mast cell tumours. (Q54397980)

29 May 2018

title

Canine oral mucosal mast cell tumours. (English)

1 reference

29 May 2018

0 references

1 reference

29 May 2018

author name string

J W Elliott

1 reference

29 May 2018

P Cripps

1 reference

29 May 2018

L Blackwood

1 reference

29 May 2018

S Murphy

1 reference

29 May 2018

I A Grant

1 reference

29 May 2018

publication date

11 November 2013

1 reference

29 May 2018

Veterinary and Comparative Oncology

published in

1 reference

29 May 2018

volume

1 reference

29 May 2018

issue

1 reference

29 May 2018

page(s)

101-111

1 reference

29 May 2018

Relationships between the histological grade of cutaneous mast cell tumours in dogs, their survival and the efficacy of surgical resection.

cites work

1 reference

Identification of the most common cutaneous neoplasms in dogs and evaluation of breed and age distributions for selected neoplasms.

21 January 2018

1 reference

Canine subcutaneous mast cell tumors: cellular proliferation and KIT expression as prognostic indices.

21 January 2018

1 reference

Mast cell tumors of the gastrointestinal tract in 39 dogs

21 January 2018

1 reference

Short- and long-term outcomes after digit amputation in dogs: 33 cases (1999-2011).

21 January 2018

1 reference

Outcomes of Dogs with Grade 3 Mast Cell Tumors: 43 Cases (1997–2007)

21 January 2018

1 reference

Biologic Behavior and Prognostic Factors for Mast Cell Tumors of the Canine Muzzle: 24 Cases (1990–2001)

21 January 2018

1 reference

Cytological lymph node evaluation in dogs with mast cell tumours: association with grade and survival

21 January 2018

1 reference

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

21 January 2018

1 reference

Response evaluation criteria for peripheral nodal lymphoma in dogs (v1.0)--a Veterinary Cooperative Oncology Group (VCOG) consensus document

21 January 2018

1 reference

Evaluation of risk and clinical outcome of mast cell tumours in pug dogs

21 January 2018

1 reference

Breed predispositions in canine mast cell tumour: a single centre experience in the United Kingdom.

21 January 2018

1 reference

Clinicopathological findings and results of bone marrow aspiration in dogs with cutaneous mast cell tumours: 157 cases (1999-2002).

21 January 2018

1 reference

European consensus document on mast cell tumours in dogs and cats

21 January 2018

1 reference

Radiation therapy for incompletely resected canine mast cell tumors

21 January 2018

1 reference

Vinblastine and prednisolone chemotherapy for surgically excised grade III canine cutaneous mast cell tumours.

21 January 2018

1 reference

Results of radiation therapy in 19 dogs with cutaneous mast cell tumor and regional lymph node metastasis

21 January 2018

1 reference

Lymph node staging of oral and maxillofacial neoplasms in 31 dogs and cats

21 January 2018

1 reference

Multicenter prospective trial of hypofractionated radiation treatment, toceranib, and prednisone for measurable canine mast cell tumors.

21 January 2018

1 reference

Efficacy of radiation therapy for incompletely resected grade-III mast cell tumors in dogs: 31 cases (1987-1998).

21 January 2018

1 reference

Radiation therapy for incompletely excised grade II canine mast cell tumors

21 January 2018

1 reference

Use of radiation and/or hyperthermia for treatment of mast cell tumors and lymphosarcoma in dogs

21 January 2018

1 reference

Treatment of canine mast cell tumours with prednisolone and radiotherapy

21 January 2018

1 reference

Radiotherapy of incompletely resected, moderately differentiated mast cell tumors in the dog: 37 cases (1989-1993).

21 January 2018

1 reference

A phase II study to evaluate the toxicity and efficacy of alternating CCNU and high-dose vinblastine and prednisone (CVP) for treatment of dogs with high-grade, metastatic or nonresectable mast cell tumours

21 January 2018

1 reference

Evaluation of prognostic markers for canine mast cell tumors treated with vinblastine and prednisone

21 January 2018

1 reference

Masitinib is safe and effective for the treatment of canine mast cell tumors

21 January 2018

1 reference

Multi-center, placebo-controlled, double-blind, randomized study of oral toceranib phosphate (SU11654), a receptor tyrosine kinase inhibitor, for the treatment of dogs with recurrent (either local or distant) mast cell tumor following surgical excis

21 January 2018

1 reference

Evaluation of neoadjuvant prednisone administration and surgical excision in treatment of cutaneous mast cell tumors in dogs

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/VCO.12071

1 reference

29 May 2018

1 reference

29 May 2018